Manzo Pharmaceuticals, Inc.
MNZO · OTC
9/30/2005 | 12/31/2004 | 9/30/2004 | |
|---|---|---|---|
| Market Cap | $4 | $2 | $3 |
| - Cash | $0 | $0 | $0 |
| + Debt | $5 | $7 | $0 |
| Enterprise Value | $9 | $8 | $3 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | -$0 |
| % Margin | – | – | – |
| EBITDA | $0 | -$3 | -$0 |
| % Margin | – | – | – |
| Net Income | -$1 | -$1 | -$1 |
| % Margin | – | – | – |
| EPS Diluted | -0.2 | -0.298 | -0.3 |
| % Growth | 32.8% | 0.8% | – |
| Operating Cash Flow | – | -$1 | – |
| Capital Expenditures | – | -$0 | – |
| Free Cash Flow | – | -$1 | – |